These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070 [TBL] [Abstract][Full Text] [Related]
3. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180. Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331 [No Abstract] [Full Text] [Related]
4. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens. Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135 [TBL] [Abstract][Full Text] [Related]
5. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472 [TBL] [Abstract][Full Text] [Related]
6. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid. Takahashi H; Anzai H; Suzuki Y; Tanikawa A; Amagai M; Nishikawa T Clin Exp Dermatol; 2004 Nov; 29(6):608-11. PubMed ID: 15550133 [TBL] [Abstract][Full Text] [Related]
7. Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II. Fukuda S; Tsuruta D; Uchiyama M; Mitsuhashi Y; Kobayashi H; Ishikawa T; Ohyama B; Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Hashimoto T Br J Dermatol; 2011 Aug; 165(2):433-5. PubMed ID: 21457206 [No Abstract] [Full Text] [Related]
8. Mucous membrane pemphigoid with immunoglobulin G autoantibodies against full-length and 120-kDa ectodomain of BP180. Choi Y; Lee SE; Fukuda S; Hashimoto T; Kim SC J Dermatol; 2011 Feb; 38(2):169-72. PubMed ID: 21269314 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of bullous pemphigoid. Ujiie H; Nishie W; Shimizu H Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134 [TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid in a patient with Parkinson's disease. Forschner A; Ulmer A; Rassner G; Fierlbeck G Eur J Dermatol; 2002; 12(6):615. PubMed ID: 12506886 [No Abstract] [Full Text] [Related]
12. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid. Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201 [TBL] [Abstract][Full Text] [Related]
13. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180. Tashima S; Konishi K; Koga H; Hashimoto T Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415 [No Abstract] [Full Text] [Related]
14. Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP). Ronaghy A; Streilein RD; Hall RP J Dermatol Sci; 2014 Apr; 74(1):93-4. PubMed ID: 24461673 [No Abstract] [Full Text] [Related]
15. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180. Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid. Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390 [TBL] [Abstract][Full Text] [Related]
17. Case of pemphigoid involving skin and mucous membrane with immunoglobulin G autoantibodies targeted to BP180 and laminin-332. Hosoda S; Suzuki M; Komine M; Fujita E; Yamada T; Murata S; Koga H; Hashimoto T; Ohtsuki M J Dermatol; 2013 Dec; 40(12):1067-8. PubMed ID: 24330181 [No Abstract] [Full Text] [Related]
18. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid. Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705 [TBL] [Abstract][Full Text] [Related]
19. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile. Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928 [TBL] [Abstract][Full Text] [Related]
20. A case of oral mucous membrane pemphigoid with IgG antibodies to integrin α6β4. Miyamoto S; Chikazu D; Yasuda T; Enomoto A; Oh-i T; Hirako Y; Tsuchisaka A; Yasukochi A; Sogame R; Teye K; Koga H; Ishii N; Qian H; Li X; Hashimoto T Br J Dermatol; 2014 Dec; 171(6):1555-7. PubMed ID: 24836504 [No Abstract] [Full Text] [Related] [Next] [New Search]